Skip to main content
logo
Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.020
0.00 (0.00%)
Jul 27, 2026, 1:09 PM EST

Nuo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
49956624630
Market Cap Growth
-33.30%44.81%169.36%-61.19%2071893.52%-99.98%
Enterprise Value
50956524600
Last Close Price
1.021.971.400.551.500.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.9528.6448.0139.99558.56-
PB Ratio
-35.68-99.22127.5923.4228.610.00
P/TBV Ratio
--127.5923.4228.610.00

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
12.1628.5247.6439.48536.08-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.80-0.620.320.250.15-
Net Debt / Equity Ratio
-0.61-0.05-0.23-0.65-0.78-1.78
Net Debt / EBITDA Ratio
-0.39-0.020.050.210.52-
Net Debt / FCF Ratio
-0.49-0.040.050.210.4611.79
Asset Turnover
2.672.180.890.250.05-
Inventory Turnover
8.216.021.680.56--
Quick Ratio
0.830.850.921.753.572.10
Current Ratio
1.111.061.462.324.392.18
Return on Equity (ROE)
---299.28%-196.34%-212.57%-62.68%
Return on Assets (ROA)
-89.65%-103.65%-100.16%-80.41%-91.97%-6.96%
Return on Capital Employed (ROCE)
-384.80%-466.60%-402.20%-263.30%-135.70%-11.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.83%-2.65%-3.55%-13.03%-5.06%-2996.37%
FCF Yield
-3.44%-1.20%-3.64%-13.05%-6.01%-3964.14%
Buyback Yield / Dilution
-3.50%-4.16%-7.95%-5.19%-32.03%-10.93%